EGFR and non-small cell lung carcinoma: CHM has shown numerous benefits for the treatment of lung cancer including preventing recurrence and metastasis [27], reducing toxicity when taken in combination with chemotherapy as well as alleviating leucopenia [12, 22, 26], enhancing therapeutic effect in non-small cell lung cancer patients harboring EGFR mutations and improving quality of life [26, 28].